Evidence map›Paper›PMID 41170025›Full record

ArticleJCEM case reports2025

Percutaneous Radiofrequency Ablation After Incomplete Adrenalectomy in a Lateralized Case of Primary Aldosteronism.

Pierre-Antonin Rigon, Nicolas Villard, Karim-Alexandre Abid, Tobias Zingg, Sandrine Eimer, Grégoire Wuerzner

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pierre-Antonin RigonDépartement de Médecine, Service de Néphrologie et d'Hypertension, Centre Hospitalier Universitaire Vaudois, and Université de Lausanne, Lausanne 1005, Switzerland.ORCID https://orcid.org/0009-0009-7775-5157
Nicolas VillardService de Radiologie et de Radiologie Interventionnelle, Centre Hospitalier Universitaire Vaudois, and Université de Lausanne, Lausanne 1005, Switzerland.
Karim-Alexandre AbidDépartement des Laboratoires, Laboratoire des Catécholamines et Peptides, Centre Hospitalier Universitaire Vaudois, Lausanne 1005, Switzerland.
Tobias ZinggService de Chirurgie Viscérale, Centre Hospitalier Universitaire Vaudois, and Université de Lausanne, Lausanne 1005, Switzerland.
Sandrine EimerService de Pathologie Clinique, Centre Hospitalier Universitaire Vaudois, and Université de Lausanne, Lausanne 1005, Switzerland.
Grégoire WuerznerDépartement de Médecine, Service de Néphrologie et d'Hypertension, Centre Hospitalier Universitaire Vaudois, and Université de Lausanne, Lausanne 1005, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary aldosteronism (PA) is a common cause of secondary hypertension. When unilateral aldosterone secretion is identified, surgery is the treatment of choice in most patients and is associated with a high cure rate. Alternative treatments, such as radiofrequency ablation (RFA), are possible options, particularly when surgery is contraindicated. A 56-year-old patient presented with hypertension secondary to PA. A left lateralization was identified after adrenal vein sampling, and the patient underwent a left laparoscopic adrenalectomy. Postoperatively, a residual adrenal remnant was detected incidentally on a computed tomography scan. Persistent PA was confirmed by hormonal workup. To avoid open laparotomy, RFA was proposed as an alternative treatment. The procedure was a biological success, leading to normalization of PA markers. Although adrenalectomy failure is rare, RFA appears to be a possible alternative treatment strategy to prevent the need for repeat surgery and its associated risks.

Indexed as

adrenalectomyprimary aldosteronismradiofrequency ablation

Identifiers

PMID41170025
PMCPMC12569595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.